GlaxoSmithKline submits regulatory application for UMEC/VI

A.B. | ShareCast | 18 Dec, 2012 12:05 - Updated: 12:58 | | |

needle

Pharmaceutical companies GlaxoSmithKline (GSK) and Theravance have submitted a regulatory application in the US for UMEC/VI medicine, used to treat chronic obstructive pulmonary disease (COPD).

UMEC/VI is an investigational once-daily LAMA/LABA combination medicine. It includes properties, umeclidinium bromide --- a long-acting muscarinic antagonist (LAMA)--- and vilanterol, a long-acting beta2 agonist which is administered using the Ellipta inhaler.

The application proposes the proprietary name Anora Ellipta and has been submitted to the US Food and Drug Administration for the long-term once-daily maintenance bronchodilator treatment of airflow obstruction in patients with COPD, including chronic bronchitis and emphysema.

Applications for UMEC/VI are also planned in the European Union and in other countries next year.

FSTE 100 company GSK is a leading research-based pharmaceutical and healthcare company.

Theravance is a biopharmaceutical company which collaborates with a number of pharmaceutical organisations.

RD

More news

22 Oct US close: Markets slide as crude price plummets

US stocks were largely unchanged on Wednesday, as the price of the crude of fell sharply.

22 Oct Front month Brent crude futures down 1.8% at $84.67 per barrel on ICE

22 Oct Lloyds to cut 9,000 jobs over next three years

Lloyds Banking Group is set announce plans to cut 9,000 jobs over the next three years.

22 Oct Tesco mulling appointment of new Chairman - FT

22 Oct GSK to deliver first Ebola vaccine by the end of 2014

British drugmaker Glaxosmithkline (GSK) announced on Wednesday that it is likely to have the world's first vaccine against Ebola by the end of 2014.

22 Oct Thursday preview: Showtime for Tesco as struggling retailer unveils H1 results

Tesco will be the company on most traders' watchlists on Thursday as the supermarket unveils its highly-anticipated half-year results.

22 Oct Metro Bank losses narrow in Q3

Metro Bank posted a £9.4m loss over the third quarter, a slight reduction from the £9.9m loss it had registered in the previous three months.

22 Oct Met Police arrests two people on suspicion of terrorism

The Metropolitan Police has confirmed it has arrested two people, including a woman suspected of "preparation of terrorist acts".

22 Oct Market overview: Admiral leads gains as market edges higher

1630: Stocks edged higher, with gains on the top flight index led by Admiral on the heels of favourable data out of AA. GlaxoSmithKline also outperformed following its latest quarterly figures. Grocers did worst ahead of tomorrow's results from Tesco. As expected the MPC kept Bank Rate unchanged at its 8 October meeting by a majority of 7 votes to 2, the minutes from that gathering revealed, although the tone of the minuets was distinctly more dovish. FTSE 100 up 27 to 6,400.

22 Oct Europe close: Stocks stabilise further

European equities ended the day higher, with periphery issues leading the way, as markets continued to regain their footing on optimism that the ECB will finally be moved to act – at some point.

Advertising

HIGHLIGHTS

MPC minutes emphasise lack of inflationary pressures

As anticipated , Carney maintained his majority of 7-2 in favour of steady policy.

VIDEOS

EUR/USD: continues its clearly bearish trend
REGISTER NOW!